Showing results (521-530 of 640) with videos related to

Sort By:
Pageof 64
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based studyMarianne Berwick, Irene Orlow, Amanda J Hummer, et al.
Cancer Causes & Control : CCC|January 9, 2007
Ambient UV, personal sun exposure and risk of multiple primary melanomasAnne Kricker, Bruce K Armstrong, Chris Goumas, et al.
Cancer Research|September 20, 2006
Population-based study of natural variation in the melanocortin-1 receptor gene and melanomaPeter A Kanetsky, Timothy R Rebbeck, Amanda J Hummer, et al.
Open Forum Infectious Diseases|December 5, 2022
Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19Carlee Moser, Jonathan Z Li, Joseph J Eron, et al.
Journal for Immunotherapy of Cancer|October 6, 2025
Pharmacokinetics and safety of subcutaneous nivolumab: results from the phase I/II CheckMate 8KX studySara Lonardi, Iwona Ługowska, Anne O'Donnell, et al.
Blood Cancer Journal|July 25, 2023
Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myelomaCarlyn Rose Tan, Andriy Derkach, David Nemirovsky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 23, 2020
Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple MyelomaSusan Bal, Heather J Landau, Gunjan L Shah, et al.
JCI Insight|December 20, 2024
Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2Sydney I Ramirez, Paul G Lopez, Farhoud Faraji, et al.
Research Square|February 26, 2024
Comparison of Infectious Complications with BCMA-directed Therapies in Multiple MyelomaAlexander Lesokhin, Karthik Nath, Tala Shekarkhand, et al.
Blood Advances|September 29, 2023
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groupsUrvi A Shah, Erin Moshier, Andriy Derkach, et al.
Pageof 64